• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Collection and handling of 24-hour urine specimens for measurement of analytes related to renal calculi.

作者信息

Ng R H, Menon M, Ladenson J H

出版信息

Clin Chem. 1984 Mar;30(3):467-71.

PMID:6697501
Abstract

Analysis for calcium, magnesium, phosphorus, oxalate, uric acid, and creatinine in 24-h urine collections is often needed for the differential diagnosis of patients with renal calculi. Considerable attention has been given to improving the methods of analysis, but improper sample collection and processing can cause significant errors for calcium and oxalate in urine samples not treated with acid and for uric acid in urine samples not treated with base. The errors are related to the concentration of the analyte, the interval the sample is stored before analysis, and the original pH of the urine sample. We describe here a system of sequential acidification (to pH 1.5) and alkalinization (to pH 9) of 24-h urine samples, followed by heating at 56 degrees C for 10 min. This procedure allows accurate analysis for all the above analytes in the same 24-h collection of urine. We validated the sample-treatment protocol for 80 24-h urine collections.

摘要

相似文献

1
Collection and handling of 24-hour urine specimens for measurement of analytes related to renal calculi.
Clin Chem. 1984 Mar;30(3):467-71.
2
[Questionable significance of the chemical analysis of a single 24-hour urine sample in recurrent calcium oxalate nephrolithiasis].[单次24小时尿液样本化学分析在复发性草酸钙肾结石中的可疑意义]
Klin Wochenschr. 1986 May 2;64(9):411-6. doi: 10.1007/BF01727526.
3
Preservation of urine samples for metabolic evaluation of stone-forming patients.用于结石形成患者代谢评估的尿液样本保存
Urol Res. 2006 Oct;34(5):329-37. doi: 10.1007/s00240-006-0064-2. Epub 2006 Aug 4.
4
Urine composition in patients with renal stone disease during treatment with allopurinol.接受别嘌呤醇治疗的肾结石病患者的尿液成分
Scand J Urol Nephrol. 1980;14(1):65-71. doi: 10.3109/00365598009181193.
5
The composition of four-hour urine samples from patients with calcium oxalate stone disease.草酸钙结石病患者四小时尿液样本的成分
Br J Urol. 1987 Oct;60(4):301-6. doi: 10.1111/j.1464-410x.1987.tb04972.x.
6
Study of inhibitor and nucleator activities in calcium stone formers.钙结石患者中抑制剂和成核剂活性的研究。
Proc Eur Dial Transplant Assoc. 1983;20:445-9.
7
Circadian variations of blood and urinary constituents in renal stone formers.肾结石患者血液和尿液成分的昼夜变化。
Prog Clin Biol Res. 1990;341B:551-7.
8
Effectiveness and mode of action of orthophosphates in patients with calcareous renal calculi.正磷酸盐对含钙肾结石患者的疗效及作用方式
Trans Am Clin Climatol Assoc. 1972;83:113-24.
9
Calcium oxalate crystalluria and urine saturation in recurrent renal stone-formers.复发性肾结石患者的草酸钙结晶尿症与尿液饱和度
Clin Sci. 1971 May;40(5):365-74. doi: 10.1042/cs0400365.
10
A risk of inaccuracy in biochemical analysis of urinary stone-forming salts.尿结石形成盐类生化分析中存在不准确的风险。
J Urol. 1984 Sep;132(3):486-9. doi: 10.1016/s0022-5347(17)49701-1.

引用本文的文献

1
Urine and stone analysis for the investigation of the renal stone former: a consensus conference.尿液和结石分析在肾结石成因研究中的应用:共识会议。
Urolithiasis. 2021 Feb;49(1):1-16. doi: 10.1007/s00240-020-01217-3. Epub 2020 Oct 13.
2
Shortage of Cellular ATP as a Cause of Diseases and Strategies to Enhance ATP.细胞内三磷酸腺苷(ATP)短缺作为疾病病因及增强ATP的策略
Front Pharmacol. 2019 Feb 19;10:98. doi: 10.3389/fphar.2019.00098. eCollection 2019.
3
Randomized controlled trial of febuxostat versus allopurinol or placebo in individuals with higher urinary uric acid excretion and calcium stones.
随机对照试验:非布司他对比别嘌醇或安慰剂治疗高尿酸尿症合并钙结石患者
Clin J Am Soc Nephrol. 2013 Nov;8(11):1960-7. doi: 10.2215/CJN.01760213. Epub 2013 Aug 8.
4
Preservation of urine samples for metabolic evaluation of stone-forming patients.用于结石形成患者代谢评估的尿液样本保存
Urol Res. 2006 Oct;34(5):329-37. doi: 10.1007/s00240-006-0064-2. Epub 2006 Aug 4.
5
Problems in the metabolic evaluation of renal stone disease: audit of intra-individual variation in urine metabolites.
Urol Res. 2006 Aug;34(4):249-54. doi: 10.1007/s00240-006-0053-5. Epub 2006 May 6.